A. Malik
Chief U.S. Commercial Officer, EVP
Pfizer Inc. · PFE
$9.4M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A filed March 12, 2026. Prior years are from that filing's three-year table.
Catalog as of September 15, 2026. Not a live market feed.
- Salary
- $1.4M
- Stock Awards
- $2.3M
- Option Awards
- $2.2M
- Incentives
- $2.9M
- Other
- $611K
Compensation History
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,386,817 | $2,281,630 | $9,429,227 |
| 2024 | $1,344,825 | $1,127,148 | $8,294,270 |
| 2023 | $1,294,800 | $1,336,257 | $5,420,734 |
Current Position
- Company
- Pfizer Inc.
- Title
- Chief U.S. Commercial Officer, EVP
- Ticker
- PFE · NYSE
- Fiscal Year
- 2025
SEC Sources
Fiscal years below are columns from the latest DEF 14A Summary Compensation Table (filed March 12, 2026), not separate historical filings.
| Fiscal Year | Source |
|---|---|
| 2025 | View SEC filing |
| 2024 | View SEC filing |
| 2023 | View SEC filing |
Accession 0000078003-26-000033.
Other Pfizer Executives
A. Bourla
Chairman And Chief Executive Officer
Pfizer · PFE
$27.6M
FY 2025 · DEF 14A
D. Denton
Chief Financial Officer, EVP
Pfizer · PFE
$9.7M
FY 2025 · DEF 14A
C. Boshoff
Chief Scientific Officer And President, Research & Development
Pfizer · PFE
$10M
FY 2025 · DEF 14A
D. Lankler
Chief Legal Officer, EVP
Pfizer · PFE
$9.1M
FY 2025 · DEF 14A